| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 07/27/2006 | US20060167046 Histamine h3 receptor antagonists, preparation and therapeutic uses |
| 07/27/2006 | US20060167043 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 07/27/2006 | US20060167015 Inhibitors of tyrosine kinases |
| 07/27/2006 | US20060167014 Piperazine compounds and medicinal use thereof |
| 07/27/2006 | US20060167012 Sulfonyl-substituted bicyclic compounds as modulators of PPAR |
| 07/27/2006 | US20060167010 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
| 07/27/2006 | US20060167008 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/27/2006 | US20060167007 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 07/27/2006 | US20060167004 4(Phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 07/27/2006 | US20060167001 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2006 | US20060166995 Piperidine-n-oxide-derivatives |
| 07/27/2006 | US20060166991 Pyridine carboxamide derivatives and their use as pesticides |
| 07/27/2006 | US20060166986 Novel stereoselective synthesis of benzimidazole sulfoxides |
| 07/27/2006 | US20060166983 Indole derivatives as ppar modulators |
| 07/27/2006 | US20060166982 Isotopically labelly indlinone derivatives and process for their preparation |
| 07/27/2006 | US20060166963 Processes for producing 4-aminoquinazolines |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166960 also informulation with an H1 receptor antagonist; inflammatory diseases, allergic conditions, obesity, metabolic syndrome and central nervous system disorders |
| 07/27/2006 | US20060166936 Diaminotriazole compounds useful as inhibitors of protein kinases |
| 07/27/2006 | US20060166894 Ace-inhibitors having antioxidant and no-donor activity |
| 07/27/2006 | US20060166829 N-Heterocycl phenyl-substituted cyclic ketoenols |
| 07/27/2006 | US20060165599 Near infrared imaging agent |
| 07/27/2006 | US20060165598 Using water soluble dyes; contrast media for fluorescence |
| 07/27/2006 | CA2595205A1 Heteroaryl substituted piperazinyl-pyridine analogues |
| 07/27/2006 | CA2595173A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | CA2594777A1 Indoles useful in the treatment of inflamation |
| 07/27/2006 | CA2594773A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2593155A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2565965A1 Pde4b inhibitors and uses therefor |
| 07/26/2006 | EP1683804A2 Platinum complex and luminescent element |
| 07/26/2006 | EP1683794A1 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 07/26/2006 | EP1682537A1 Modulators of cellular adhesion |
| 07/26/2006 | EP1682535A1 Heteroaryl derivatives as ppar activators |
| 07/26/2006 | EP1682534A2 Pyrimidin-4-one compounds, compositions, and methods |
| 07/26/2006 | EP1682533A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3- [(2-methyl-1h-imidazole-1-yl)methyl]-4h-carbazol-4-one or its salt |
| 07/26/2006 | EP1682532A1 Pyrimidines as inhibitors of phosphoinositide-3-kinases (pi3k) |
| 07/26/2006 | EP1682531A2 Substituted heterocyclic compounds and methods of use |
| 07/26/2006 | EP1682530A1 Substituted pyrrole-indoles as inhibitors of pai-1 |
| 07/26/2006 | EP1682520A1 Amide derivatives |
| 07/26/2006 | EP1682519A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 07/26/2006 | EP1682516A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/26/2006 | EP1682121A1 Use of crth2 antagonist compounds in therapy |
| 07/26/2006 | EP1192950B1 Therapeutic drugs for dermatitis exhibiting a biphasic skin reaction containing chymase inhibitors as the active ingredient |
| 07/26/2006 | EP0655061B2 Method of increasing the spf rating and compounds suitable for increasing the spf rating of fibre or fabric |
| 07/26/2006 | CN1809559A Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 07/26/2006 | CN1809557A 化合物 Compound |
| 07/26/2006 | CN1809554A 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 07/26/2006 | CN1809539A Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 |
| 07/26/2006 | CN1809538A Cis-2,4,5-triaryl-imidazolines |
| 07/26/2006 | CN1809360A 4-anilino-quinazoline derivatives as antiproliferative agents |
| 07/26/2006 | CN1809346A Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor XA and VIIA inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then |
| 07/26/2006 | CN1807427A Oxazolidinone analog compound containing triazol radical and its preparation method and uses |
| 07/26/2006 | CN1807426A Heteroaryl urea neuropeptide y y5 receptor antagonists |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/25/2006 | US7081532 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide or salt; antiproliferative agent |
| 07/25/2006 | US7081470 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/25/2006 | US7081466 anticarcinogenic agents with improved efficacy against multidrug resistant tumors; improved oral bioavailability and side effect reduction |
| 07/25/2006 | US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/25/2006 | US7081454 Anticancer agents |
| 07/25/2006 | CA2395869C 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives |
| 07/25/2006 | CA2259218C Tetrahydrobenzindole compound |
| 07/20/2006 | WO2006076710A2 Preparation of crude candesartan cilexetil |
| 07/20/2006 | WO2006076702A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ĸB ACTIVITY AND USE THEREOF |
| 07/20/2006 | WO2006076644A2 Heteroaryl sulfonamides and ccr2 |
| 07/20/2006 | WO2006075619A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006074799A2 5-pyrrolidinylsulfonyl isatin derivatives |
| 07/20/2006 | WO2006060678A3 Novel processes for the preparation of cgrp-receptor antagonists and intermediates thereof |
| 07/20/2006 | WO2006059234A3 Bicyclic amides as kinase inhibitors |
| 07/20/2006 | WO2006052546A3 Pyrazolylmethyl heteroaryl derivatives |
| 07/20/2006 | WO2006037775A8 Enantiopure heterocyclic compound useful for the preparation of peptides which can be potentially used as medicaments |
| 07/20/2006 | WO2006018846A3 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4h- carbazol-4-one and ondansetron therefrom |
| 07/20/2006 | WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 07/20/2006 | US20060161002 Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 07/20/2006 | US20060160886 Chemical compounds |
| 07/20/2006 | US20060160885 Chemical compounds |
| 07/20/2006 | US20060160882 Indoline derivatives |
| 07/20/2006 | US20060160880 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI |
| 07/20/2006 | US20060160879 Indoles useful in the treatment of inflammation |
| 07/20/2006 | US20060160864 Acrylamide derivative, process for producing the same, and use |
| 07/20/2006 | US20060160863 Polymorphic and amorphous forms of 2-{3-[(E)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-N-(4-hydroxy-but-2-ynyl)benzamide |
| 07/20/2006 | US20060160861 Novel nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 07/20/2006 | US20060160860 Synthesis of polyamine compounds |
| 07/20/2006 | US20060160858 Administering N-Cyclopropyl-2-{3-[(E)-2-(4-methyl-pyridin-2-yl)-vinyl]-1H-indazol-6-ylamino}-benzamide for treating ophthalmic disease which is age related macular degeneration, diabetic retinopathy, or neovascular glaucoma |
| 07/20/2006 | US20060160856 Diarylurea derivatives and their use as chloride channel blockers |
| 07/20/2006 | US20060160855 [5-(1-Ethyl-piperidin-4-ylamino)-1H-indol-2-yl]-morpholin-4-yl-methanone; useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors; treatment of obesity or eating disorders in human being or animals |
| 07/20/2006 | US20060160854 Methods for the treatment of cachexia |
| 07/20/2006 | US20060160853 2-[(4-Benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as nr2b receptor antagonists |
| 07/20/2006 | US20060160847 2,4-Dihalogen-6-(c2-c3alkyl)-phenyl substituted tetramic acid derivatives |
| 07/20/2006 | US20060160821 N-[4-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenyl]-2-(4-chlorophenylaminocarbonylamino)-acetamide; thrombosis prevention |
| 07/20/2006 | US20060160820 Substituted piperazine carbamates |
| 07/20/2006 | US20060160819 Substitued piperazine carbamates |
| 07/20/2006 | US20060160818 Ocular hypotensive agent |
| 07/20/2006 | US20060160817 4-phenylpyrimidine compounds such as 4-(2-Fluoro-phenyl)-2-morpholin-4-yl-pyrimidine-5-carboxylic acid benzyl-isopropyl-amide, useful as inhibitors of voltage-gated sodium channels and/or calcium channels, for the treatment of pain, psychological and neurodegenerative disorders |
| 07/20/2006 | US20060160814 Phosphodiesterase 10 inhibitors |
| 07/20/2006 | US20060160813 For therapy of bronchitis, allergic bronchitis, bronchial asthma, emphysema, COPD and allergic rhinitis |
| 07/20/2006 | US20060160808 New carboxylic acid derivatives, their preparation and their use |
| 07/20/2006 | US20060160807 mitogen-activated protein (MAP) kinase inhibitor; antiproliferative, anticarcinogenic agent; autoimmune disorders; |
| 07/20/2006 | US20060160806 N-benzyl-N'-{(3R)-1-[(6-methylpyridin-3-yl)carbonyl]pyrrolidin-3-yl}urea |